lymphangioma
lymphangioma
Explore linked clinical trials. Standard reference: MONDO:00020136 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation. | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Lymphatic Abnormalities, Neoplasm, Lymphatic Tissue, Neoplasms by Histologic Type, cystic hygroma, lymphangioma, lymphatic system disorder, neoplasm | Recruiting | Phase 2 / Phase 3 | 2026-10-09 | NCT05948943 | |
| Radiological Diagnosis of Pediatric Neck Swellings | Branchial Cleft Anomalies, Branchioma, Cysts, Hemic and Lymphatic Diseases, Myosarcoma, Neoplasm, Lymphatic Tissue, Neoplasms by Histologic Type, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, cystic hygroma, extraskeletal myxoid chondrosarcoma, hemangioma, lipoma, lymphadenitis, lymphangioma, lymphatic system disorder, myomatous neoplasm, myxoid chondrosarcoma, neoplasm, rhabdomyosarcoma, sarcoma, thyroglossal duct cyst, vascular cancer | Active, not recruiting | Not stated | 2026-07-30 | NCT07734805 | |
| A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Lymphatic Abnormalities, Neoplasm, Lymphatic Tissue, Neoplasms by Histologic Type, PIK3CA-related overgrowth spectrum, Skin and Connective Tissue Diseases, arteriovenous hemangioma/malformation, cardiovascular disorder, cystic hygroma, lymphangioma, lymphatic malformation, lymphatic system disorder, neoplasm, skin disorder, skin vascular disease, vascular disorder, vascular malformation, venous hemangioma | Recruiting | Phase 2 | 2026-05-05 | NCT05983159 | |
| SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Lymphatic Abnormalities, Neoplasm, Lymphatic Tissue, Neoplasms by Histologic Type, cardiovascular disorder, lymphangioma, lymphatic system disorder, microcystic lymphatic malformation, neoplasm, vascular malformation | Active, not recruiting | Phase 3 | 2026-03-27 | NCT06239480 | |
| A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neoplasm, Lymphatic Tissue, Neoplasms by Histologic Type, arteriovenous hemangioma/malformation, cardiovascular disorder, hemangioendothelioma, hemangioma, lymphangioma, melanocytic neoplasm, melanocytic nevus, neoplasm, vascular cancer, vascular disorder, vascular malformation, venous hemangioma | Not yet recruiting | Phase 2 | 2026-03-17 | NCT07477548 | |
| Institution of an Italian Registry and Biobank for Biological Sample Collection | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Lymphatic Abnormalities, Neoplasm, Lymphatic Tissue, Neoplasms by Histologic Type, lymphangioma, lymphatic malformation, lymphatic system disorder, neoplasm | Recruiting | Not applicable | 2025-03-25 | NCT06892964 |